THE NEWLY LICENSED HEPATITIS-B VACCINE - CHARACTERISTICS AND INDICATIONS FOR USE

被引:93
作者
KRUGMAN, S
机构
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1982年 / 247卷 / 14期
关键词
D O I
10.1001/jama.247.14.2012
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:2012 / 2015
页数:4
相关论文
共 15 条
[1]  
BEASLEY RP, 1981, LANCET, V2, P1129
[2]   A NEW ANTIGEN IN LEUKEMIA SERA [J].
BLUMBERG, BS ;
ALTER, HJ ;
VISNICH, S .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1965, 191 (07) :541-&
[3]  
DIENSTAG JL, 1981, HEPATOLOGY, V1, P506
[4]   PURIFIED AND INACTIVATED HUMAN HEPATITIS-B VACCINE - PROGRESS REPORT [J].
HILLEMAN, MR ;
BUYNAK, EB ;
ROEHM, RR ;
TYTELL, AA ;
BERTLAND, AU ;
LAMPSON, GP .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1975, 270 (02) :401-404
[5]  
HILLEMAN MR, 1981, PERSPECT VIROL, V11, P219
[6]   VIRAL HEPATITIS, TYPE-B (MS-2 STRAIN) - ACTIVE IMMUNIZATION [J].
KRUGMAN, S ;
GILES, JP ;
HAMMOND, J .
JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1971, 217 (01) :41-+
[7]   IMMUNOGENIC EFFECT OF INACTIVATED HEPATITIS-B VACCINE - COMPARISON OF 20-MU-G AND 40-MU-G DOSES [J].
KRUGMAN, S ;
HOLLEY, HP ;
DAVIDSON, M ;
SIMBERKOFF, MS ;
MATSANIOTIS, N .
JOURNAL OF MEDICAL VIROLOGY, 1981, 8 (02) :119-121
[8]  
MAUPAS P, 1981, LANCET, V1, P289
[9]  
MAUPAS P, 1976, LANCET, V1, P1367